JP2019537446A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019537446A5 JP2019537446A5 JP2019524226A JP2019524226A JP2019537446A5 JP 2019537446 A5 JP2019537446 A5 JP 2019537446A5 JP 2019524226 A JP2019524226 A JP 2019524226A JP 2019524226 A JP2019524226 A JP 2019524226A JP 2019537446 A5 JP2019537446 A5 JP 2019537446A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- sequence
- composition
- pharmaceutical composition
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662421516P | 2016-11-14 | 2016-11-14 | |
| US62/421,516 | 2016-11-14 | ||
| PCT/KR2017/010897 WO2018088694A2 (ko) | 2016-11-14 | 2017-09-28 | 인위적으로 조작된 sc 기능 조절 시스템 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019537446A JP2019537446A (ja) | 2019-12-26 |
| JP2019537446A5 true JP2019537446A5 (enExample) | 2020-11-12 |
| JP7338937B2 JP7338937B2 (ja) | 2023-09-05 |
Family
ID=62109586
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019524226A Active JP7338937B2 (ja) | 2016-11-14 | 2017-09-28 | 人工的に操作されたｓｃ機能制御システム |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12331086B2 (enExample) |
| EP (2) | EP3539980A4 (enExample) |
| JP (1) | JP7338937B2 (enExample) |
| KR (2) | KR102437228B1 (enExample) |
| CN (1) | CN110248957B (enExample) |
| AU (1) | AU2017358122B2 (enExample) |
| BR (1) | BR112019009725A2 (enExample) |
| RU (2) | RU2768043C2 (enExample) |
| WO (1) | WO2018088694A2 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2022103641A (ru) * | 2017-09-28 | 2022-03-18 | Тулджен Инкорпорейтед | Искусственная модификация генома для регуляции экспрессии гена |
| US11572574B2 (en) | 2017-09-28 | 2023-02-07 | Toolgen Incorporated | Artificial genome manipulation for gene expression regulation |
| JP7410154B2 (ja) * | 2018-09-12 | 2024-01-09 | インスティチュート フォー ベーシック サイエンス | 遺伝的に変異された細胞の死滅誘導組成物及び該組成物を用いた遺伝的に変異された細胞の死滅誘導方法 |
| EP3798301A1 (en) * | 2019-09-25 | 2021-03-31 | KWS SAAT SE & Co. KGaA | Promoter repression |
| WO2021184021A1 (en) * | 2020-03-13 | 2021-09-16 | Codiak Biosciences, Inc. | Extracellular vesicle-aso constructs targeting pmp22 |
| CN114621922A (zh) * | 2022-02-15 | 2022-06-14 | 中山大学附属第五医院 | 一种大鼠海绵体神经来源施旺细胞的提取纯化和培养方法 |
| WO2025079278A1 (ja) * | 2023-10-10 | 2025-04-17 | 国立大学法人 東京医科歯科大学 | シャルコー・マリー・トゥース病の処置剤 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100613038B1 (ko) * | 2004-07-07 | 2006-08-16 | 공주대학교 산학협력단 | 염색체 17ｐ11.2-ｐ12 지역의 중복을 제외한 유전자돌연변이를 발병 원인으로 하는 ＣＭＴ 질환의 진단방법및 진단키트 |
| US8124749B2 (en) * | 2007-06-12 | 2012-02-28 | Case Western Reserve University | Targeted cell death |
| EP2912175B1 (en) | 2012-10-23 | 2018-08-22 | Toolgen Incorporated | Composition for cleaving a target dna comprising a guide rna specific for the target dna and cas protein-encoding nucleic acid or cas protein, and use thereof |
| WO2014093622A2 (en) | 2012-12-12 | 2014-06-19 | The Broad Institute, Inc. | Delivery, engineering and optimization of systems, methods and compositions for sequence manipulation and therapeutic applications |
| EP3674411A1 (en) * | 2013-06-17 | 2020-07-01 | The Broad Institute, Inc. | Delivery, engineering and optimization of tandem guide systems, methods and compositions for sequence manipulation |
| WO2015048577A2 (en) * | 2013-09-27 | 2015-04-02 | Editas Medicine, Inc. | Crispr-related methods and compositions |
| EP3090044B1 (en) * | 2013-12-26 | 2021-11-03 | The General Hospital Corporation | Multiplex guide rnas |
| EP3152319A4 (en) * | 2014-06-05 | 2017-12-27 | Sangamo BioSciences, Inc. | Methods and compositions for nuclease design |
| WO2016021973A1 (ko) | 2014-08-06 | 2016-02-11 | 주식회사 툴젠 | 캄필로박터 제주니 crispr/cas 시스템 유래 rgen을 이용한 유전체 교정 |
| EP4434589A3 (en) | 2015-10-23 | 2025-05-14 | President and Fellows of Harvard College | Evolved cas9 proteins for gene editing |
-
2017
- 2017-09-28 WO PCT/KR2017/010897 patent/WO2018088694A2/ko not_active Ceased
- 2017-09-28 AU AU2017358122A patent/AU2017358122B2/en active Active
- 2017-09-28 BR BR112019009725-2A patent/BR112019009725A2/pt unknown
- 2017-09-28 RU RU2019118283A patent/RU2768043C2/ru active
- 2017-09-28 EP EP17869218.2A patent/EP3539980A4/en not_active Withdrawn
- 2017-09-28 JP JP2019524226A patent/JP7338937B2/ja active Active
- 2017-09-28 RU RU2022105597A patent/RU2022105597A/ru unknown
- 2017-09-28 US US16/349,672 patent/US12331086B2/en active Active
- 2017-09-28 EP EP21166447.9A patent/EP3896162B1/en active Active
- 2017-09-28 KR KR1020170126636A patent/KR102437228B1/ko active Active
- 2017-09-28 CN CN201780083263.5A patent/CN110248957B/zh active Active
-
2022
- 2022-08-24 KR KR1020220105836A patent/KR102621539B1/ko active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019537446A5 (enExample) | ||
| WO2012172277A4 (en) | Simian adenovirus and hybrid adenoviral vectors | |
| CN113056477B (zh) | 用于在疾病的预防和/或治疗中使用的疫苗 | |
| JP2018518457A5 (enExample) | ||
| RU2557312C2 (ru) | Поксвирусные онколитические векторы | |
| JP2014516536A5 (enExample) | ||
| JP2020203894A5 (enExample) | ||
| JP2020531032A5 (enExample) | ||
| RU2017143893A (ru) | РЕЖИМЫ ПРАЙМ-БУСТ, ВКЛЮЧАЮЩИЕ ВВЕДЕНИЕ ПО МЕНЬШЕЙ МЕРЕ ОДНОЙ КОНСТРУКЦИИ мРНК | |
| JP2018520997A5 (enExample) | ||
| CA3031416C (en) | Recombinant vaccinia virus and use thereof | |
| JP2017122120A5 (enExample) | ||
| JP2018509936A5 (enExample) | ||
| JP2020511115A5 (enExample) | ||
| BRPI0820576B1 (pt) | Uso de um poxvírus oncolítico compreendendo um gene i4l e/ou f4l defectivo ou uma composição compreendendo o mesmo | |
| KR20180095511A (ko) | 표적화된 암 요법 | |
| WO2012145509A3 (en) | Adeno-associated-virus rep sequences, vectors, and viruses | |
| WO2020223362A8 (en) | Compositions useful for treatment of pompe disease | |
| JP2017507943A5 (enExample) | ||
| JP2018534255A5 (enExample) | ||
| MY209964A (en) | Isolated modified vp1 capsid protein of aav5 | |
| JP2017533910A5 (enExample) | ||
| RU2022105597A (ru) | Искусственно созданная система управления функцией шк | |
| JP2013518599A5 (enExample) | ||
| JP2019528755A5 (enExample) |